Unknown EARLY_PHASE1 INTERVENTIONAL 1-arm NCT04507932

Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT

Sponsor: Peking Union Medical College Hospital

Interventions 68Ga-FAPI

Updated 6 times since 2020 Last updated: Jan 24, 2021 Started: Aug 1, 2020 Primary completion: Jan 1, 2022 Completion: Dec 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Inflammatory Bowel Disease and is currently ongoing. Peking Union Medical College Hospital leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status
Feb 2021 — Feb 2023 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Feb 2021 [monthly]

Not Yet Recruiting EARLY_PHASE1

▶ Show 1 earlier version

Sep 2020 — Jan 2021 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China